Trichy-Ravi Remedy Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2018
About Trichy-Ravi Remedy Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thangavel Ranjith and Mummachi Thangavel serve as directors at the Company.
- CIN/LLPIN
U51909TN2017PTC119110
- Company No.
119110
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2017
- Date of AGM
21 Dec 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Trichy-Ravi Remedy Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thangavel Ranjith  | Director | 16-Oct-2017 | Current |
| Mummachi Thangavel | Director | 16-Oct-2017 | Current |
Financial Performance of Trichy-Ravi Remedy Drugs.
Trichy-Ravi Remedy Drugs Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Trichy-Ravi Remedy Drugs?
In 2018, Trichy-Ravi Remedy Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kolkata-Ravi Specialities Pharma Private LimitedActive 6 yearsThangavel Ranjith and Mummachi Thangavel are mutual person
Imphal-Ravispecialitiespharma Private LimitedActive 6 years 11 monthsThangavel Ranjith and Mummachi Thangavel are mutual person
- Trichy-Ravi Speed Parcel Services Private LimitedActive 7 years 1 month
Thangavel Ranjith and Mummachi Thangavel are mutual person
- Trichy-Ravi Consumer Care Private LimitedActive 7 years 3 months
Thangavel Ranjith and Mummachi Thangavel are mutual person
- Ravi Worldwide Medicines Private LimitedActive 7 years 2 months
Thangavel Ranjith and Mummachi Thangavel are mutual person
- Rsp-Ravi Specialities Pharma (Opc) Private LimitedActive 7 years 9 months
Thangavel Ranjith is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trichy-Ravi Remedy Drugs?
Unlock and access historical data on people associated with Trichy-Ravi Remedy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trichy-Ravi Remedy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trichy-Ravi Remedy Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.